rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TLX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Telix CEO Adds to Shareholding, Underscoring Equity Alignment

      Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.

      Oct 27The Globe and MailTLX
      Telix Pharmaceuticals: The ITM Deal Could Strengthen The Long-Term Buy Case (NASDAQ:TLX)

      Telix Pharmaceuticals maintains a Buy rating, driven by robust 3Q26 performance and the strategic ITM acquisition. Read more on TLX stock here.

      Oct 23Seeking AlphaTLX
      Telix Reports Third Quarter 2026 Financial Performance
      Oct 20Yahoo FinanceTLX
      Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan (NASDAQ:TLX)
      Oct 8Seeking AlphaTLX
      Telix Adds 436,366 New Shares to ASX Listing

      Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.

      Oct 5The Globe and MailTLX
      Telix Pharmaceuticals Reports Lapse of Conditional Equity Securities

      Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.

      Oct 5The Globe and MailTLX
      Analysts Offer Insights on NA Companies: FedEx (FDX), Sunbelt Rentals Holdings Inc (SUNB) and Telix Pharmaceuticals Limited Unsponsored ADR (TLX)

      Tipranks Press Release.

      Oct 1The Globe and MailTLXFDXSUNB
      Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade

      The average of price targets set by Wall Street analysts indicates a potential upside of 83.4% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

      Sep 30Yahoo FinanceTLX
      Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging

      Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation for the Company's BiPASS® program.

      Sep 30Yahoo FinanceTLX
      Telix Director David Gill Boosts Nasdaq ADS Stake

      Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.

      Sep 26The Globe and MailTLX
      Analysts’ Top NA Picks: MillerKnoll (MLKN), Telix Pharmaceuticals Limited Unsponsored ADR (TLX)

      Detailed price information for Telix Pharmaceuticals Limited ADR (TLX-Q) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailMLKNTLX
      Telix Pharmaceuticals (ASX:TLX) ITM Deal Puts Valuation Back In Focus
      Sep 23Yahoo FinanceTLX
      Telix (TLX) to Buy Germany’s ITM for up to $2.35 Billion to Lock in its Cancer Isotope Supply

      Telix Pharmaceuticals Limited (NASDAQ:TLX) agreed on September 21 to acquire ITM Isotope Technologies Munich SE. The deal is worth up to $2.35 billion. Telix will pay $1.65 billion upfront, before cash and debt. A further $700 million follows if ITM’s lead drug wins approval and hits sales targets. Telix is paying mostly in its own […]

      Sep 22Yahoo FinanceTLX
      Telix Pharmaceuticals Limited (TLX) Discusses Strategic Overview and Oncology Pipeline at Research and Development Day - Slideshow (NASDAQ:TLX) 2026-09-22
      Sep 22Seeking AlphaTLX
      Telix Pharmaceuticals (ASX:TLX) Lands $2.35 Billion Deal To Reshape Radiopharmaceutical Reach
      Sep 22Yahoo FinanceTLX
      Telix Pharma Stock Is Falling Monday: What's Going On? - Telix Pharmaceuticals (NASDAQ:TLX)

      Telix Pharmaceuticals acquires ITM Isotope for $1.65B to create a radiopharmaceutical leader. Here is what investors need to know.

      Sep 21BenzingaTLX
      Telix Pharmaceuticals Limited Rings the Closing Bell

      About This EventTelix Pharmaceuticals Limited (Nasdaq:TLX), a commercial-stage global radiopharmaceutical company, advancing precision diagnostics and targeted radionuclide therapies to improve outcomes for people with cancer, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Dr. Christian Behrenbruch, Managing Director & Group Chief Executive Officer rings the Closing Bell.

      Sep 21NasdaqTLX
      Telix Pharmaceuticals Limited (TLX) Telix Pharmaceuticals Limited, - M&A Call - Slideshow (NASDAQ:TLX) 2026-09-21
      Sep 21Seeking AlphaTLX
      Telix to buy Germany’s ITM Isotope for $1.65B to expand radiopharma footprint (TLX:NASDAQ)

      Telix Pharmaceuticals to buy Germany’s ITM Isotope in a $1.65B deal, boosting radiopharma scale and 2026 revenue outlook—read the details now.

      Sep 21Seeking AlphaTLX
      Telix Pharmaceuticals: 'Buy' On Pixclara FDA Approval And TLX591-Tx Part 2 Advancement
      Sep 16Seeking AlphaTLX
      Telix climbs for second trading day following Pixclara approval

      Telix jumps on FDA approval of Pixclara for glioma FET-PET imaging. Read more here.

      Sep 15Seeking AlphaTLX
      Telix applies to quote new shares issued under employee equity plans

      Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.

      Sep 15The Globe and MailTLX
      FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug
      Sep 14BenzingaTLX
      FDA approves Telix brain cancer imaging drug Pixclara (TLX:NASDAQ)
      Sep 14Seeking AlphaTLX
      Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

      MELBOURNE, Australia and INDIANAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference, both in New York, NY. Presentation details: Morgan Stanley 24th Annual Global Healthcare Co

      Sep 9Yahoo FinanceTLXMS
      Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
      Sep 1Yahoo FinanceTLX
      Telix Appoints David Gill as Chair
      Aug 31Yahoo FinanceTLX
      Telix Pharmaceuticals: Execution Is The Name Of The Game Here (NASDAQ:TLX)
      Aug 24Seeking AlphaTLX

      This is the newest page. Registered accounts read further back.